Megha Sinha, founder and CEO of Kolter AI and Kamet Consulting Group, spoke with PharmTech at the beginning of 2026 about her ...
Regulatory Optimisation Group efforts are converging on a future-state lifecycle change process, shifting from document-based ...
A distributed “hub-and-spoke” operation could register as one establishment, reducing administrative friction while improving ...
A 2026–2027 joint work program operationalizes EMA–EISMEA cooperation to move European Innovation Council-funded projects ...
Kolter AI, discusses how digital twins run pharma supply chains but miss the regulatory execution needed to launch changes ...
In part 1 of a 3-part interview, Brent Wilhelm, Senior Vice President of Global Supply Chain, Cencora, brings more than 30 years of healthcare industry experience to a role focuse ...
Manufacturing digitalization is expanding via MES, eQMS, automation, and data-integrity initiatives, yet cross-functional ...
Economic asymmetry after cartridge introduction drives a design philosophy centered on minimizing false acceptances and protecting API, with >99.5% first-pass yield as the principal success criterion.
Cencora, discusses why pharma supply chains still run on historical demand data and how AI could close the real-time visibility gap.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results